What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Endocrinology
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Surgery, Risk factor and Osteoporosis.
Internal medicine is closely attributed to Placebo in his research.
The study incorporates disciplines such as Cortical bone, Calcium metabolism and Parathyroid hormone in addition to Endocrinology.
In his study, Forearm is strongly linked to Cohort study, which falls under the umbrella field of Surgery.
The Risk factor study combines topics in areas such as Odds ratio, Relative risk, Blood pressure, Atrial fibrillation and Type 2 diabetes.
His Osteoporosis research is multidisciplinary, incorporating perspectives in Hormone replacement therapy, Age related and Vertebral body.
His most cited work include:
- Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. (454 citations)
- Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry (395 citations)
- Vitamin D and the elderly (339 citations)
What are the main themes of his work throughout his whole career to date?
Leif Mosekilde mainly focuses on Internal medicine, Endocrinology, Osteoporosis, Surgery and Vitamin D and neurology.
His work on Placebo expands to the thematically related Internal medicine.
His work carried out in the field of Endocrinology brings together such families of science as Calcium metabolism, Parathyroid hormone and Osteocalcin.
His Osteoporosis research is multidisciplinary, relying on both Physical therapy, Menopause and Raloxifene.
His studies in Surgery integrate themes in fields like Relative risk, Case-control study, Cohort study and Risk factor.
His Vitamin D and neurology study combines topics from a wide range of disciplines, such as Vitamin and Secondary hyperparathyroidism.
He most often published in these fields:
- Internal medicine (69.07%)
- Endocrinology (46.39%)
- Osteoporosis (21.31%)
What were the highlights of his more recent work (between 2012-2019)?
- Internal medicine (69.07%)
- Endocrinology (46.39%)
- Vitamin D and neurology (16.49%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Endocrinology, Vitamin D and neurology, Hypoparathyroidism and Placebo.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Surgery.
The various areas that Leif Mosekilde examines in his Endocrinology study include Calcium metabolism, Parathyroid hormone and Familial hypocalciuric hypercalcemia.
His Vitamin D and neurology research incorporates themes from Vitamin, Myocardial infarction and Animal science.
Leif Mosekilde has researched Hypoparathyroidism in several fields, including Postural stability and Epidemiology.
His studies examine the connections between Placebo and genetics, as well as such issues in Leptin, with regards to Osteocalcin and Weight loss.
Between 2012 and 2019, his most popular works were:
- Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. (145 citations)
- Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. (129 citations)
- Postsurgical hypoparathyroidism--risk of fractures, psychiatric diseases, cancer, cataract, and infections. (110 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Cancer
Leif Mosekilde focuses on Internal medicine, Endocrinology, Hypoparathyroidism, Placebo and Vitamin D and neurology.
His Methylmalonic acid study in the realm of Internal medicine interacts with subjects such as Trustworthiness.
His Hypoparathyroidism study combines topics in areas such as Quality of life, Parathyroid hormone and Pediatrics.
Leif Mosekilde focuses mostly in the field of Placebo, narrowing it down to matters related to Randomized controlled trial and, in some cases, Relative risk, Angina, Meta-analysis and Physical therapy.
His biological study spans a wide range of topics, including Myocardial infarction, Acute coronary syndrome, Vitamin and Cohort study.
The Bone remodeling study which covers Osteoporosis that intersects with Orthopedic surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
